NO930145L - Modifisert baculovirus, fremgangsmaate ved fremstilling derav, og ekspresjonsvektorer erholdt fra denne baculovirus - Google Patents

Modifisert baculovirus, fremgangsmaate ved fremstilling derav, og ekspresjonsvektorer erholdt fra denne baculovirus

Info

Publication number
NO930145L
NO930145L NO93930145A NO930145A NO930145L NO 930145 L NO930145 L NO 930145L NO 93930145 A NO93930145 A NO 93930145A NO 930145 A NO930145 A NO 930145A NO 930145 L NO930145 L NO 930145L
Authority
NO
Norway
Prior art keywords
baculovirus
pct
modified
procedures
producing
Prior art date
Application number
NO93930145A
Other languages
English (en)
Other versions
NO930145D0 (no
Inventor
Gerard Devauchelle
Martine Cerutti
Claire Cahoreau
Marianne Martin
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient filed Critical Agronomique Inst Nat Rech
Publication of NO930145D0 publication Critical patent/NO930145D0/no
Publication of NO930145L publication Critical patent/NO930145L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO93930145A 1990-07-18 1993-01-15 Modifisert baculovirus, fremgangsmaate ved fremstilling derav, og ekspresjonsvektorer erholdt fra denne baculovirus NO930145L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR909009143A FR2664905B1 (fr) 1990-07-18 1990-07-18 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
PCT/FR1991/000588 WO1992001801A1 (fr) 1990-07-18 1991-07-17 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus

Publications (2)

Publication Number Publication Date
NO930145D0 NO930145D0 (no) 1993-01-15
NO930145L true NO930145L (no) 1993-03-15

Family

ID=9398840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930145A NO930145L (no) 1990-07-18 1993-01-15 Modifisert baculovirus, fremgangsmaate ved fremstilling derav, og ekspresjonsvektorer erholdt fra denne baculovirus

Country Status (14)

Country Link
US (1) US5571709A (no)
EP (1) EP0651815B1 (no)
JP (1) JP3076833B2 (no)
AT (1) ATE151462T1 (no)
AU (1) AU660419B2 (no)
CA (1) CA2087270C (no)
DE (1) DE69125632T2 (no)
FR (1) FR2664905B1 (no)
HU (1) HUT62937A (no)
IE (1) IE912525A1 (no)
NO (1) NO930145L (no)
NZ (1) NZ239032A (no)
PT (1) PT98357B (no)
WO (1) WO1992001801A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400382B (de) * 1994-06-24 1995-12-27 Inject Star Poekelmasch Vorrichtung zum quetschen und auflockern von fleisch
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
JP2003040297A (ja) * 2001-08-06 2003-02-13 Toppan Printing Co Ltd オーバーキャップ付封緘キャップ
EP2305312B1 (en) 2001-10-10 2015-03-04 ratiopharm GmbH Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)
ES2561985T3 (es) 2001-10-10 2016-03-01 Ratiopharm Gmbh Remodelación y glicoconjugación de anticuerpos
EP2338333B1 (en) 2003-04-09 2017-09-06 ratiopharm GmbH Glycopegylation methods and proteins/peptides produced by the methods
KR20070007086A (ko) 2004-02-02 2007-01-12 암브룩스, 인코포레이티드 변형된 인간의 4 개의 나선형 다발 폴리펩티드 및 이의용도
NZ551335A (en) 2004-06-18 2010-03-26 Ambrx Inc Antibodies and fragments thereof comprising an non naturally encoded amino acid coupled to a linker
CA2569381A1 (en) 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
EP1828224B1 (en) 2004-12-22 2016-04-06 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
NZ584597A (en) 2004-12-22 2011-09-30 Ambrx Inc Modified human growth hormone
BRPI0519568C8 (pt) * 2004-12-22 2022-06-14 Ambrx Inc Aminoacil-trna sintetase (rs), composições que compreendem a dita aminoacil-trna sintetase, célula de levedura, célula fúngica, célula não eucariótica, vetor que codifica uma rs, polinucleotídeo e ainda método para produzir um polipeptídeo em uma célula com um aminoácido selecionado em uma posição especificada
CN103520735B (zh) 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
MX2007007591A (es) 2004-12-22 2007-07-25 Ambrx Inc Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
CA2609205A1 (en) 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
EP1937824B1 (en) * 2005-08-18 2013-03-13 Ambrx, Inc. COMPOSITIONS OF tRNA AND USES THEREOF
NZ567234A (en) * 2005-11-08 2011-09-30 Ambrx Inc Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
DK2339014T3 (en) 2005-11-16 2015-07-20 Ambrx Inc Methods and compositions comprising non-natural amino acids
SG10201405661QA (en) * 2005-12-14 2014-10-30 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
US9133495B2 (en) 2006-09-08 2015-09-15 Ambrx, Inc. Hybrid suppressor tRNA for vertebrate cells
KR20090052360A (ko) 2006-09-08 2009-05-25 암브룩스, 인코포레이티드 척추동물 세포에서의 서프레서 ｔＲＮＡ 전사
WO2008030558A2 (en) * 2006-09-08 2008-03-13 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
DK2068909T3 (da) 2007-03-30 2012-08-06 Ambrx Inc Modificerede FGF-21-polypeptider og anvendelse heraf
KR20100019467A (ko) * 2007-05-02 2010-02-18 암브룩스, 인코포레이티드 변형된 인터페론 베타 폴리펩티드 및 그의 용도
MX2010005317A (es) 2007-11-20 2010-06-02 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
ES2654387T3 (es) 2008-07-23 2018-02-13 Ambrx, Inc. Polipéptidos G-CSF bovinos modificados y sus usos
UA106731C2 (uk) 2008-09-26 2014-10-10 Амбркс, Інк. Модифіковані поліпептиди еритропоетину тварин та їх застосування
NZ592249A (en) 2008-09-26 2013-03-28 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
CA2800182A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
JP2013515081A (ja) 2009-12-21 2013-05-02 アンブルックス，インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用
AU2010341516B2 (en) 2009-12-21 2014-01-16 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
CA2790380A1 (en) 2010-02-18 2011-08-25 Mount Sinai School Of Medicine Vaccines for use in the prophylaxis and treatment of influenza virus disease
EP3248615A1 (en) 2010-03-30 2017-11-29 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
PE20140160A1 (es) 2010-08-17 2014-02-08 Ambrx Inc Polipeptidos de relaxina modificados y sus usos
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
ES2864764T3 (es) 2011-05-11 2021-10-14 Childrens Medical Center Composición inmunogénica que presenta múltiples antígenos, y métodos y usos de la misma
CA2842392C (en) * 2011-07-27 2020-09-15 Genethon Improved baculovirus expression systems
CA2849434A1 (en) 2011-09-20 2013-03-28 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
US9968670B2 (en) 2012-12-18 2018-05-15 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
US9791445B2 (en) 2013-01-28 2017-10-17 Kansas State University Research Foundation Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
EA036697B1 (ru) 2014-10-24 2020-12-09 Бристол-Майерс Сквибб Компани Модифицированные полипептиды fgf-21 и их применение
EP3247389A4 (en) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai INFLUENZAVIRUSSCHUTZIMPFPLÄNE
JP7237344B2 (ja) 2016-06-15 2023-03-13 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルス血球凝集素タンパク質及びその使用
EP3580232B1 (en) 2017-02-08 2023-09-20 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
AT519931A1 (de) * 2017-05-12 2018-11-15 Kepler Univ Gmbh Herstellung von armierter DNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485810T2 (de) * 1983-05-27 1992-12-10 Texas A & M University Syst Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.

Also Published As

Publication number Publication date
CA2087270C (fr) 2001-12-04
FR2664905A1 (fr) 1992-01-24
AU8232491A (en) 1992-02-18
FR2664905B1 (fr) 1994-08-12
NO930145D0 (no) 1993-01-15
WO1992001801A1 (fr) 1992-02-06
DE69125632D1 (de) 1997-05-15
CA2087270A1 (fr) 1992-01-19
DE69125632T2 (de) 1997-10-23
IE912525A1 (en) 1992-01-29
JPH06500010A (ja) 1994-01-06
EP0651815B1 (fr) 1997-04-09
PT98357B (pt) 1999-01-29
US5571709A (en) 1996-11-05
HUT62937A (en) 1993-06-28
HU9300118D0 (en) 1993-04-28
JP3076833B2 (ja) 2000-08-14
PT98357A (pt) 1992-05-29
ATE151462T1 (de) 1997-04-15
EP0651815A1 (fr) 1995-05-10
NZ239032A (en) 1993-10-26
AU660419B2 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
NO930145L (no) Modifisert baculovirus, fremgangsmaate ved fremstilling derav, og ekspresjonsvektorer erholdt fra denne baculovirus
RU2125558C1 (ru) Способ получения 2',3'-дидезокси-3'-тиацитидина или 2',3'-дидезокси-3'-тиа-5-фторцитидина, обогащенный энантиомером нуклеозид, способ получения 1,3-оксатиолана, способ получения обогащенного энантиомером 2-ацилокси-5-ацилокси-1,3-оксатиолана, энантиомеры, способ расщепления энантиомеров нуклеозида
FI950409A0 (fi) Yhdistelmä soluja, DNA-rakenteita, vektoreita ja menetelmiä fytaattia hajoittavien entsyymien ilmentämiseksi toivotuissa suhteissa
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
ATE229076T1 (de) Cis elemente des ölkörperproteins als regulationische signale
YU122891A (sh) Postupak za dobijanje novog izolata trichoderma harzianum t-39, fungicidalnih jedinjenja
ATE217649T1 (de) Synthetische eukaryotische promotoren welche zwei induzierbare elemente enthalten
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
Pons et al. Efficient syntheses of enantiomerically pure L and D-allothreonines and (S) and (R) isoserines
DE69408099D1 (de) 5-Methyluridin-Verfahren zur Herstellung von 2',3'-didehydro-3'-desoxythymidin (d4T) im Grossmassstab
ATE258551T1 (de) (2-(2-thienyl)-ethylamino)-(2-halophenyl)- acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung
DK0749489T3 (da) Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe
DE69627166D1 (de) Verfahren zur herstellung von 2-chlor-5-chlomethyl-thiazol-derivaten
DK0630365T3 (da) Fremgangsmåde til fremstilling af beta-phenylisoserin og analoge deraf
EP0292101A3 (en) Process for the preparation of 3'-azido-3'-deoxythymidine and intermediates
GB2302874B (en) Novel proteins
EA199901059A1 (ru) Способ получения энантиомерно обогащенных n-производных лактамов
YU46247B (sh) Postupak za dobijanje 2,2',4,4',6,6'-heksanitrostilbena specifične čistoće i nasipne mase
FR2700338B1 (fr) Nouvelle séquence pro permettant la secrétion de protéines hétérologues à partir d'une cellule de levure.
DK0651811T3 (da) Promotor fra ribosomproteingenet RP28 af K. Lactis og anvendelse deraf
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
MX9702141A (es) Procedimiento para la produccion asi como para el uso de acarviosil-transferasa en la transformacion de homologos de acarbosa en acarbosa, para la produccion de homologos de acarbosa.
FR2485000B1 (no)
Norrie Reproduction of the rosy boa, Lichanura trivirgata.